Anniken B.
- Country
- Spain
- Department
- Ophthalmology
Research Overview
- Evaluation of Efficacy and Safety of Intravitreal EYE103 Versus Ranibizumab in Diabetic Macular Edema: A Randomized, Double-Masked, Multi-Center Study
- Efficacy of Topical Somatostatin (COLIRIOBCN070660) in Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Pozelimab and Cemdisiran, Alone or in Combination, on Geographic Atrophy Progression in Age-Related Macular Degeneration
Data & Insights
Has run more than one trial at 63 of 118 partner sites.
Specializations
Ophthalmology & Retinal Disorders
The investigator specializes in treating Geographic Atrophy (GA), a severe form of age-related macular degeneration (AMD). Their research focuses on innovative therapeutic approaches for managing progressive retinal conditions.
- Advanced retinal disease management
- Macular degeneration therapies
- Vision preservation strategies
Particular attention is given to developing treatments that address the underlying mechanisms of retinal deterioration.
Complement System Research
The investigator explores the role of the complement system in ocular diseases, with particular emphasis on Complement Component 5 (C5) inhibition strategies for treating retinal disorders.
- Complement pathway modulation
- Systemic complement inhibition
- Novel therapeutic proteins
Their work encompasses both systemic and local therapeutic approaches for managing ocular conditions.
Gene Therapy Applications
The investigator studies advanced gene therapy interventions for ocular diseases, including novel intravitreal treatments for geographic atrophy and related conditions.
- Intravitreal gene delivery
- AAV-based therapeutics
- Ocular gene transfer
Focus areas include the development and evaluation of genetic approaches for treating progressive eye disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.